Changes related to "Fluorouracil (5-FU)"

Jump to: navigation, search

This is a list of changes made recently to pages linked from a specified page (or to members of a specified category). Pages on your watchlist are bold.

Recent changes options
Legend:
N
This edit created a new page (also see list of new pages)
m
This is a minor edit
b
This edit was performed by a bot
(±123)
The page size changed by this number of bytes
Show last 50 | 100 | 250 | 500 changes in last 1 | 3 | 7 | 14 | 30 days
Hide minor edits | Show bots | Hide anonymous users | Hide registered users | Hide my edits

Show new changes starting from 15:14, 25 June 2018
   
Page name:

25 June 2018

 m   15:03  Gastric cancer‎ (diff | hist) . . (+898). . Jwarner (talk | contribs) (S-1 monotherapy {{#subobject:ec10ef|Regimen=1}})
 m   14:21  Colon cancer‎‎ (3 changes | history) . . (+3,706). . [Jwarner‎ (3×)]
 m    14:21 (cur | prev) . . (+1,692). . Jwarner (talk | contribs) (mFOLFOX6 {{#subobject:32d6c5|Regimen=1}})
 m    14:15 (cur | prev) . . (+10). . Jwarner (talk | contribs) (Variant #1 {{#subobject:205ad6|Variant=1}})
 m    14:01 (cur | prev) . . (+2,004). . Jwarner (talk | contribs) (Advanced or metastatic disease, first-line)
 m   13:39  Diffuse large B-cell lymphoma - historical‎‎ (2 changes | history) . . (+5). . [Jwarner‎ (2×)]
 m    13:39 (cur | prev) . . (0). . Jwarner (talk | contribs) (Chemotherapy)
 m    13:28 (cur | prev) . . (+5). . Jwarner (talk | contribs)
 m   13:37  Pancreatic cancer‎‎ (2 changes | history) . . (+140). . [Jwarner‎ (2×)]
 m    13:37 (cur | prev) . . (+31). . Jwarner (talk | contribs) (FOLFIRINOX {{#subobject:aaa3c4|Regimen=1}})
 m    13:34 (cur | prev) . . (+109). . Jwarner (talk | contribs) (Gemcitabine & nab-Paclitaxel {{#subobject:fbd698|Regimen=1}})

24 June 2018

 m   09:59  Breast cancer‎ (diff | hist) . . (+398). . Jwarner (talk | contribs) (Capecitabine monotherapy {{#subobject:e058c1|Regimen=1}})
 m   09:47  Esophageal cancer‎ (diff | hist) . . (+3,390). . Jwarner (talk | contribs)

23 June 2018

 m   18:17  Esophageal cancer‎‎ (2 changes | history) . . (+3,602). . [Jwarner‎ (2×)]
 m    18:17 (cur | prev) . . (+2,897). . Jwarner (talk | contribs)
 m    09:54 (cur | prev) . . (+705). . Jwarner (talk | contribs) (Metastatic or locally advanced disease (non-radiation/surgery candidate))
 m   16:36  Head and neck cancer‎‎ (5 changes | history) . . (+2,459). . [Jwarner‎ (5×)]
 m    16:36 (cur | prev) . . (+56). . Jwarner (talk | contribs)
 m    16:12 (cur | prev) . . (-1). . Jwarner (talk | contribs) (Chemotherapy)
 m    16:10 (cur | prev) . . (+137). . Jwarner (talk | contribs)
 m    15:06 (cur | prev) . . (-32). . Jwarner (talk | contribs) (Regimen {{#subobject:8e0178|Variant=1}})
 m    15:04 (cur | prev) . . (+2,299). . Jwarner (talk | contribs)

22 June 2018

 m   16:59  Bladder cancer‎ (diff | hist) . . (+1,598). . Jwarner (talk | contribs) (Locally advanced or metastatic disease, subsequent lines)
 m   16:03  Diffuse large B-cell lymphoma - historical‎ (diff | hist) . . (+13). . Jwarner (talk | contribs)

20 June 2018

 m   16:11  Hepatocellular carcinoma‎ (diff | hist) . . (+8). . Jwarner (talk | contribs) (Subsequent treatment)
     15:05  Breast cancer‎‎ (6 changes | history) . . (+3,855). . [Jwarner‎ (6×)]
 m    15:05 (cur | prev) . . (+17). . Jwarner (talk | contribs) (Variant #1, 20 mg/m2 weekly {{#subobject:96cac2|Variant=1}})
 m    11:01 (cur | prev) . . (-8). . Jwarner (talk | contribs) (Paclitaxel monotherapy, q3wk {{#subobject:3e5448|Regimen=1}})
 m    11:00 (cur | prev) . . (+1,748). . Jwarner (talk | contribs) (Gemcitabine & Bevacizumab {{#subobject:134dbe|Regimen=1}})
      10:56 (cur | prev) . . (+2,990). . Jwarner (talk | contribs) (Metastatic disease, maintenance after first-line therapy)
 m    10:52 (cur | prev) . . (+1,616). . Jwarner (talk | contribs) (Gemcitabine monotherapy {{#subobject:b240d6|Regimen=1}})
 m    10:49 (cur | prev) . . (-2,508). . Jwarner (talk | contribs) (GT (Taxol) {{#subobject:1285e|Regimen=1}})
 m   11:30  Pancreatic NET‎ (diff | hist) . . (+3). . Jwarner (talk | contribs) (Lanreotide & Interferon alfa {{#subobject:9c5a59|Regimen=1}})
 m   11:07  Prostate cancer‎ (diff | hist) . . (+34). . Jwarner (talk | contribs) (Ipilimumab & RT {{#subobject:33 |Regimen=1}})
 m   10:46  Esophageal cancer‎ (diff | hist) . . (+180). . Jwarner (talk | contribs) (FOLFOX-C {{#subobject:e51095|Regimen=1}})
 m   10:43  Colon cancer‎ (diff | hist) . . (+288). . Jwarner (talk | contribs)

19 June 2018

 m   23:01  Esophageal cancer‎ (diff | hist) . . (-35). . Jwarner (talk | contribs)
 m   22:57  Rectal cancer‎‎ (2 changes | history) . . (+151). . [Jwarner‎ (2×)]
 m    22:57 (cur | prev) . . (+79). . Jwarner (talk | contribs) (Fluorouracil, Folinic acid, Levamisole, RT {{#subobject:45b35a|Regimen=1}})
 m    17:51 (cur | prev) . . (+72). . Jwarner (talk | contribs) (Neoadjuvant chemoradiotherapy)
 m   22:39  Pancreatic cancer‎‎ (2 changes | history) . . (+186). . [Jwarner‎ (2×)]
 m    22:39 (cur | prev) . . (+72). . Jwarner (talk | contribs) (Gemcitabine monotherapy {{#subobject:34e70d|Regimen=1}})
 m    22:38 (cur | prev) . . (+114). . Jwarner (talk | contribs)
 m   17:42  Diffuse large B-cell lymphoma - historical‎‎ (4 changes | history) . . (+704). . [Jwarner‎ (4×)]
 m    17:42 (cur | prev) . . (+28). . Jwarner (talk | contribs) (Relapsed or refractory, further lines of therapy)
 m    17:39 (cur | prev) . . (+352). . Jwarner (talk | contribs) (Relapsed or refractory, salvage therapy)
 m    17:17 (cur | prev) . . (+1,211). . Jwarner (talk | contribs) (MINE {{#subobject:aff118|Regimen=1}})
 m    17:17 (cur | prev) . . (-887). . Jwarner (talk | contribs) (NOAC {{#subobject:c6c400|Regimen=1}})
 m   17:41  Gastric cancer‎ (diff | hist) . . (+21). . Jwarner (talk | contribs) (ECC {{#subobject:36cac7|Regimen=1}})
 m   17:24  Breast cancer‎ (diff | hist) . . (-260). . Jwarner (talk | contribs)
 m   10:58  Hepatocellular carcinoma‎‎ (7 changes | history) . . (+3,100). . [Jwarner‎ (7×)]
 m    10:58 (cur | prev) . . (+10). . Jwarner (talk | contribs) (Preceding treatment)
 m    10:57 (cur | prev) . . (+24). . Jwarner (talk | contribs) (TACE, then 5-FU {{#subobject:572d2d|Regimen=1}})
 m    10:55 (cur | prev) . . (+1,951). . Jwarner (talk | contribs)
 m    10:34 (cur | prev) . . (0). . Jwarner (talk | contribs) (TACE {{#subobject:50f9da|Regimen=1}})
 m    09:48 (cur | prev) . . (+71). . Jwarner (talk | contribs) (TACE {{#subobject:50f9da|Regimen=1}})
 m    09:22 (cur | prev) . . (+1,003). . Jwarner (talk | contribs) (Sorafenib monotherapy {{#subobject:b38f69|Regimen=1}})
 m    09:19 (cur | prev) . . (+41). . Jwarner (talk | contribs) (Radioembolization {{#subobject:4f040c|Regimen=1}})

18 June 2018

 m   23:14  Esophageal cancer‎ (diff | hist) . . (+149). . Jwarner (talk | contribs)
 m   22:52  Nasopharyngeal carcinoma‎ (diff | hist) . . (+8). . Jwarner (talk | contribs) (Locally advanced disease, induction)